Professor Michael Osborn studied medicine at Guys & St Thomas Hospitals, London qualifying in 1995. He became a member of the Royal College of Surgeons in 2000 and a Fellow of the Royal College of Pathologists in 2004. Currently he works as a consultant histopathologist for North West London Pathology at Imperial College Healthcare NHS Trust, London where he is clinical lead. His working time is divided between post mortems, diagnostic gastrointestinal histopathology, bowel cancer screening and teaching. He runs an intercalated BSc “Humanities, Philosophy & Law” at Imperial College, London. During the COVID-19 pandemic he and colleagues at Imperial College published work relating to findings in fatal COVID-19 infection. He was elected President of the Royal College of Pathologists (RCPath) in November 2020 having previously been on the RCPath council and having had a variety of college roles including chair of their Cellular Pathology Speciality Advisory Committee and Death Investigation Committee. 

Follow on Twitter:  @mike4path

A Diplomate of the American Board of Pathology (Combined Anatomic and Clinical Pathology, and Immunopathology) with 30 years of experience.  Currently, a Full member (Professor) and the Chairman of the Department of Cell Therapy & Applied Genomics, and a Consultant, Molecular and Immunopathology, the Chairman of Research Council and the Co-Director of The Cancer Care Informatics Program at King Hussein Cancer Center, Amman-Jordan. Prolific academician/scientist with 20 plus grants, 120 plus manuscripts, 2 book chapters and 130 plus abstracts. Serves as Inspection Team leader for the College of American Pathologists (CAP).  Well acquainted with AABB, FACT, JACIE, ASHI and GTP/GMP standards and guidelines. 

Follow on Twitter:  @atbakhi

Academician Professor Dr Lai-Meng Looi is Malaysia’s inaugural National Distinguished Professor, and consultant histopathologist at the University Malaya Medical Centre.  She co-chaired the InterAcademy Partnership for Health (2010-2016) when this global network of National Sciences and Medical Academies extended initiatives into global health, the social determinants of health, urban health, and young physician leadership capacity-building. She is the Founding President of the Malaysian College of Pathologists and former President of the World Association of Societies of Pathology and Laboratory Medicine, with specific interest in laboratory accreditation and capacity-building in countries-in-need.  Current engagements include the Lancet Commission on Diagnostics, RCPath International Regional Advisor (Western Pacific) and Honorary Professor of the Chinese Academy of Medical Sciences-Peking Union Medical College.

Leah Mnango is a Pathologist, working at Muhimbili National Hospital, Dar Es Salaam-Tanzania. Graduated from Kilimanjaro Christian Medical University College and entered postgraduate training in Muhimbili University of Health and Allied Sciences. She is very interested in research, and work with Paediatric Oncology team in Tanzania for care of Children with Cancer.  Currently she is a Lead Pathologist in a Project titled; Evaluation and Transfer of Mobile whole slide tissue Scanners and Liquid biopsies to deliver fast and precise diagnosis for Improved outcomes of Children and Young adult with EBV- driven Lymphoma; A joint Tanzania, Uganda and Oxford University UK project, supported by NIHR-RIGHT.

Nasir Rajpoot is Professor of Computational Pathology at the Computer Science department of the University of Warwick, where he started his academic career as a Lecturer (Assistant Professor) in 2001. He also holds an Honorary Scientist position at the Department of Pathology, University Hospitals Coventry & Warwickshire NHS Trust since 2016. Prof Rajpoot is the founding Director of Tissue Image Analytics (TIA) Centre (previously the TIA lab) at Warwick since 2012. In Autumn 2017, he was awarded the Wolfson Fellowship by the UK Royal Society and the Turing Fellowship by the Alan Turing Institute, the UK’s national institute for data science and artificial intelligence.Current focus of research in the TIA Centre, led by Prof Rajpoot, is on developing algorithms for the analysis of digitised pathology images, with applications to computer-assisted grading of cancer and image-based markers for prediction of cancer progression and survival. He has been active in the digital pathology community for almost a decade now, having co-chaired several meetings in the histology image analysis (HIMA) series since 2008 and served as a founding PC member of the SPIE Digital Pathology meeting since 2012. Prof Rajpoot served as the President of the European Congress on Digital Pathology (ECDP), which was held at Warwick in April 2019. Since Jan 2019, he acts as Co-Director of the £15m PathLAKE national centre of excellence on AI in pathology, leading the computational arm of the centre.

Follow on Twitter: @nmrajpoot

Dr Abdulaziz AlAjlan has been the Chairman of the Department of Pathology and Laboratory Medicine at King Abdulaziz Medical City, Riyadh, Kingdom of Saudi Arabia since 2009. A Consultant Dermatopathologist, who obtained his Bachelors Degree in Medicine from King Saudi University, College of Medicine, Riyadh in 1989. He completed his fellowship in Pathology at King Saudi University in 1997. Dr Alajlan obtained his MRCPath in 1998 from UK in Anatomic Pathology. He did his fellowship in Dermatopathology at Ackerman's Academy of Dermatopathology in 2000. He has an extensive list of published scientific papers and books. He is a reference dermatopathologist in the Middle East with large number of referrals from pathologists and dermatopathologists. He is a founder of Saudi Board of Pathology as well as Leader in Digital Pathology. He is the founder of Digital Pathology descriptive seminar an annual event which takes place in March ://Saudidigitalpathology.org.

Dr Bethany Williams is a Digital Pathology Research Fellow at Leeds Teaching Hospitals NHS Trust and the University of Leeds, and the Lead for Digital Pathology Training, Education and PPI at the National Pathology Imaging Co-Operative. She is a thought leader in evidence based digital pathology training and validation, and her scientific papers on digital diagnostic accuracy form the basis of the Royal College of Pathologists’ guidelines for safe, effective digital deployment. Her body of research earned her the Pathological Society’s medal for research impact, and she is regularly invited to speak at international conferences as an authority on the digital pathology evidence base, practical deployment and patient safety.

Naresh Kikkeri, Professor and Section Head of Pathology at the Fred Hutchinson Cancer Center and Professor of Pathology at the University of Washington in Seattle, USA. He is a Visiting Professor at the Centre of Haematology, Imperial College London. He is an expert haematopathologist known internationally for his expertise in lymphoma and bone marrow pathology.  Earlier, he worked at the Hammersmith Hospital and the Imperial College for 17 years. He has held many key positions in several UK institutions and for The Royal College of Pathologists. He previously trained and worked in India and has been involved in research in many African countries.

Peter Carey trained in Newcastle and Cambridge. His subspecialist interests are diagnostic haematopathology, paediatric haematology and haemoglobinopathy. He was the founding lead clinician for the North of England Haematological Oncology Diagnostic Service (NEHODS). He was the lead examiner for the morphology section of the final FRCPath examination 2015-18. He is a member of the Scientific Advisory Group for the UK National External Quality Assessment (NEQAS) haematology scheme. In collaboration with Paediatric Oncology colleagues, he provides a remote diagnostic telepathology service to the children’s cancer service in Blantyre, Malawi.

Professor Jo Martin CBE has been on the Board of Barts Health NHS Trust, been National Clinical Director of Pathology for NHS England from 2013 to 2016, was President of the Royal College of Pathologists from 2017 to 2020, and is now National Specialty Advisor for NHS England and Improvement. Jo’s clinical expertise is in the pathology of gastrointestinal motility disorders. Professor of Pathology and Director of the Blizard Institute at Queen Mary University London, UK, with research interests in diagnostics, she is a founder of Biomoti, for cancer drug delivery. She created the education eCPD app and leads the Pathology Portal Digital Training programme.

Clare is Associate Professor of Pathology, Nuffield Department of Surgical Sciences, University of Oxford and an Honorary Urological Pathology Consultant at the John Radcliffe Hospital. Clare’s research interests are in multi-modal and digital pathology and image analysis in cancer, primarily testis and prostate. As well as her academic group, Clare’s diverse roles include NIHR BRC 3 Sub-Theme lead for experimental pathology,  CM-Path Workstream 4 Lead and RCPath Thames Valley Regional College Advisor . She is co-lead of the PathLAKE Oxford consortium - a unique multi-disciplinary team which provides knowledge, skills and expertise in prostate pathology, image analysis and AI.  https://www.pathlake.org/our-team/

I founded X-WOW, a social enterprise to connect people in medicine through pathology to educate, consult & network. One of our activities involve donating (or facilitating the donated) pathology equipment (microscopes and whole slide scanners) to pathologists with limited resources, which allow them to obtain high-level expert pathology consultation from experienced volunteers remotely. This has a meaningful impact to patient care in low-income countries.  I am also a data scientist working at the University of Cambridge, where I apply my data analysis skill to healthcare data to help improve healthcare and the long-term prevention, diagnosis, and treatment of rare disease.

Follow on Twitter: https://twitter.com/X_WowCom
Connect on Facebook: https://www.facebook.com/xwowcom
Visit the website: https://www.x-wow.com/